Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species

被引:36
|
作者
Whibley, Natasha [1 ]
Gaffen, Sarah L. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA
[2] Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA
关键词
Candida albicans; Non-albicans species; Fungal immunity; INNATE LYMPHOID-CELLS; CATIONIC ANTIMICROBIAL PEPTIDES; PATTERN-RECOGNITION RECEPTOR; HOST-DEFENSE; MEDICALLY IMPORTANT; CYTOKINE PRODUCTION; TH17; CELLS; OPPORTUNISTIC INFECTIONS; ADJUNCTIVE IMMUNOTHERAPY; INTRACELLULAR SURVIVAL;
D O I
10.1016/j.cyto.2015.07.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fungal genus Candida encompasses numerous species that inhabit a variety of hosts, either as commensal microbes and/or pathogens. Candida species are a major cause of fungal infections, yet to date there are no vaccines against Candida or indeed any other fungal pathogen. Our knowledge of immunity to Candida mainly comes from studies on Candida albicans, the most frequent species associated with disease. However, non-albicans Candida (NAC) species also cause disease and their prevalence is increasing. Although research into immunity to NAC species is still at an early stage, it is becoming apparent that immunity to C. albicans differs in important ways from non-albicans species, with important implications for treatment, therapy and predicted demographic susceptibility. This review will discuss the current understanding of immunity to NAC species in the context of immunity to C. albicans, and highlight as-yet unanswered questions. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [21] How does temperature trigger biofilm adhesion and growth in Candida albicans and two non-Candida albicans Candida species?
    Casagrande Pierantoni, Debora
    Corte, Laura
    Casadevall, Arturo
    Robert, Vincent
    Cardinali, Gianluigi
    Tascini, Carlo
    MYCOSES, 2021, 64 (11) : 1412 - 1421
  • [22] Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species
    Bellavita, Rosa
    Maione, Angela
    Merlino, Francesco
    Siciliano, Antonietta
    Dardano, Principia
    De Stefano, Luca
    Galdiero, Stefania
    Galdiero, Emilia
    Grieco, Paolo
    Falanga, Annarita
    PHARMACEUTICS, 2022, 14 (02)
  • [23] Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities
    Muadcheingka, Thaniya
    Tantivitayakul, Pornpen
    ARCHIVES OF ORAL BIOLOGY, 2015, 60 (06) : 894 - 901
  • [24] Candida albicans versus non-albicans bloodstream infections: The comparison of risk factors and outcome
    Chi, Hung-Wei
    Yang, Ya-Sung
    Shang, Shi-Ta
    Chen, Ke-Hung
    Yeh, Kuo-Ming
    Chang, Feng-Yee
    Lin, Jung-Chung
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (05) : 369 - 375
  • [25] Invasive candidiasis in intensive care units in China: Risk factors and prognoses of Candida albicans and non-albicans Candida infections
    Gong, Xiaoying
    Luan, Ting
    Wu, Xingmao
    Li, Guofu
    Qiu, Haibo
    Kang, Yan
    Qin, Bingyu
    Fang, Qiang
    Cui, Wei
    Qin, Yingzhi
    Li, Jianguo
    Zang, Bin
    AMERICAN JOURNAL OF INFECTION CONTROL, 2016, 44 (05) : E59 - E63
  • [26] Candida albicans infection and intestinal immunity
    Tong, Yiqing
    Tang, Jianguo
    MICROBIOLOGICAL RESEARCH, 2017, 198 : 27 - 35
  • [27] Innate immunity to Candida albicans
    Kiyoura, Yusuke
    Tamai, Riyoko
    JAPANESE DENTAL SCIENCE REVIEW, 2015, 51 (03) : 59 - 64
  • [28] Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species
    Grahl, Nora
    Demers, Elora G.
    Crocker, Alex W.
    Hogan, Deborah A.
    MSPHERE, 2017, 2 (03):
  • [29] Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients
    Davis, Susan L.
    Vazquez, Jose A.
    McKinnon, Peggy S.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 568 - 573
  • [30] Antifungal activity of extracts and isolated compounds from Buchenavia tomentosa on Candida albicans and non-albicans
    Teodoro, Guilherme R.
    Brighenti, Fernanda L.
    Botazzo Delbem, Alberto C.
    Delbem, Adina Cleia B.
    Khouri, Sonia
    Gontijo, Aline Vidal L.
    Pascoal, Aislan C. R. F.
    Salvador, Marcos J.
    Koga-Ito, Cristiane Y.
    FUTURE MICROBIOLOGY, 2015, 10 (06) : 917 - 927